evidence for whom?: asha’s national outcomes measurement system
TRANSCRIPT
![Page 1: Evidence for whom?: ASHA’s National Outcomes Measurement System](https://reader031.vdocuments.site/reader031/viewer/2022020107/5750739c1a28abdd2e905017/html5/thumbnails/1.jpg)
Evidence for whom?: ASHA’s National OutcomesMeasurement System
Robert Mullen*
American Speech-Language-Hearing Association, 10801 Rockville Pike,
Rockville, MD 20852-3279, USA
Received 20 November 2003; accepted 6 April 2004
Abstract
The growth of managed care and increasing demands by school systems resulted in of a number of
new audiences looking for the evidence underlying the practice of speech-language pathology (SLP).
Third-party payers, operating in an environment emphasizing ‘‘return-on-investment,’’ sought data
linking expenditures on SLP services with tangible outcomes affecting resource utilization, such as
required level of care and ability to discharge. ASHA’s National Outcomes Measurement System
(NOMS) was developed to address these types of needs. This paper provides an overview of NOMS
and its intended uses in the field.
Learning outcomes: (1) Readers will understand the rationale behind the development of NOMS.
(2) Readers will be aware of the strengths and limitations of NOMS.
# 2004 Elsevier Inc. All rights reserved.
Keywords: Evidence-based practice; National Outcomes Measurement System; Functional Communication
Measures
Spurred on by the growth of managed care, the 1990s saw the emergence of a number of
new audiences looking for the evidence underlying the practice of speech-language
pathology. Third-party payers, operating in an environment emphasizing ‘‘return-on-
investment,’’ sought data linking expenditures on SLP services with tangible outcomes
affecting resource utilization, such as required level of care and ability to discharge. In
school settings, an increased emphasis on accountability led administrators, principals, and
teachers to look for evidence that SLP intervention translated into observable improvement
Journal of Communication Disorders 37 (2004) 413–417
* Tel.: þ1 301 897 5700x4265.
E-mail address: [email protected] (R. Mullen).
0021-9924/$ – see front matter # 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.jcomdis.2004.04.004
![Page 2: Evidence for whom?: ASHA’s National Outcomes Measurement System](https://reader031.vdocuments.site/reader031/viewer/2022020107/5750739c1a28abdd2e905017/html5/thumbnails/2.jpg)
in childrens’ classroom performance. In both settings, SLPs and administrators sought
data that they could use to advocate for staffing levels and to educate patients and their
families.
What united these quite diverse data needs was the fact that they almost always
involved the presentation of data to non-SLP audiences. This called into question the
extent to which data from clinical SLP research could be effectively used to address these
evidence needs. While clinical research may help us understand how to get a 4-year-old
girl from a Mean Length of Utterance (MLU; Brown, 1973) of 1.5 to an MLU of 4.0,
what the parents need to know is that this means the difference between their daughter
saying ‘‘spoon’’ versus ‘‘I dropped my spoon’’ or ‘‘I need a spoon.’’ Clinical research may
provide evidence that, using a certain protocol under certain conditions with certain
patients, SLPs can typically get those patients from a 0 to an 8 on the Complex Ideational
Material sub-score of the Boston Diagnostic Aphasia Examination (Goodglass, Kaplan, &
Barresi, 2000). While an SLP would know that this suggests that the person is much
more likely to be able to successfully live at home, it may not be terribly meaningful to a
payer.
In 1994, the American Speech-Language-Hearing Association (ASHA) established a
Task Force to develop within the Association a clearinghouse for functional outcomes
data. The clearinghouse would serve as a repository for such data, which could then
be analyzed and disseminated to clinicians as a way to meet these evidence needs.
Unfortunately, psychometrically sound, functional, and clinically meaningful measure-
ment systems could not be found, and ASHA undertook development of its own
outcomes system, which came to be known as the National Outcomes Measurement
System (NOMS).
NOMS is the umbrella term for three separate but related nationwide data collection
systems for speech-language pathology treatment outcomes. As it was the arena of adult
health care in which SLPs most acutely recognized an unmet need for outcomes data, the
first data collection system to be developed and launched was the Adult component of
NOMS. Data collection for the Adult component began in late 1998, followed by the Pre-
Kindergarten (ages 3–5) component and Schools component in 1999.
All three NOMS components have a similar structure. When a patient is admitted to SLP
services, the SLP submits an Admission form, via the Internet or as a scannable document,
which captures basic demographic and diagnostic data about the individual receiving
services. Additionally, the SLP scores the patient on one or more of a series of seven-point
scales to measure the patient’s level of functional communication. These scales, referred to
as the Functional Communication Measures (FCMs), are disorder-specific (see Table 1).
The SLP scores the patient on whichever FCM(s) correspond to the patient’s treatment
plan.
When the patient is discharged from SLP services, the SLP completes a Discharge
form. This form is used to record data about the amount and type of services provided
and to record discharge scores on the same FCMs previously gathered with the
Admission form. Movement along the FCM scales from admission to discharge is
used as the outcome measure, and it is compared to the patient characteristics and
service delivery variables in order to learn more about which factors are associated with
positive and negative outcomes. Participating sites have access to an on-line database
414 R. Mullen / Journal of Communication Disorders 37 (2004) 413–417
![Page 3: Evidence for whom?: ASHA’s National Outcomes Measurement System](https://reader031.vdocuments.site/reader031/viewer/2022020107/5750739c1a28abdd2e905017/html5/thumbnails/3.jpg)
from which they can generate reports of their site’s data as well as comparable national
data.
1. Methodological limitations and strengths
1.1. Limitations
1.1.1. Patient controls
In contrast to experimental study designs, the case series approach utilized in NOMS
does not contain any control groups. Because there are no absence-of-treatment or placebo
groups against which to compare the outcomes of the patients who did receive treatment, a
causal link between treatment and outcome cannot be established.
1.1.2. Treatment protocols
Recording of detailed descriptions of treatment protocols are beyond the scope of
NOMS, so little can be learned about the relative effectiveness of different approaches.
Further study is needed to ascertain the usefulness of the FCMs as appropriate outcomes
measures in effectiveness studies.
1.1.3. Reliability
Movement away from strictly clinical measures to more functional measures necessarily
introduces more subjectivity into the scoring of the FCMs. Reliability is much more easily
established on a test which measures how often a patient successfully completes eight
well-defined tasks, for example, than for a measure of the extent to which a student’s
participation in the classroom is limited by his speech production difficulties. In addition,
the clinician who is responsible for the patient’s treatment determines the ratings. In most
cases, that means the SLP is also being evaluated in part on the extent to which his/her
patients make progress, providing an unfortunate incentive for inflated scoring.
Table 1
Adult Functional Communication Measure: attention
Level Ability
1 Attention is non-functional. The individual is generally unresponsive to most stimuli.
2 The individual can briefly attend with consistent maximal stimulation, but not long enough to
complete even simple living tasks.
3 The individual maintains attention over time to complete simple living tasks of short duration
with consistent maximal cueing in the absence of distracting stimuli.
4 The individual maintains attention during simple living tasks of multiple steps and long duration
within a minimally distracting environment with consistent minimal cueing.
5 The individual maintains attention within simple living activities with occasional minimal cues
within distracting environments. The individual requires increased cueing to start, continue,
and change attention during complex activities.
6 The individual maintains attention within complex activities, and can attend simultaneously to
multiple demands with rare minimal cues. The individual usually uses compensatory strategies when
encountering difficulty. The individual has mild difficulty or takes more than a reasonable amount of
time to attend to multiple tasks/stimuli.
R. Mullen / Journal of Communication Disorders 37 (2004) 413–417 415
![Page 4: Evidence for whom?: ASHA’s National Outcomes Measurement System](https://reader031.vdocuments.site/reader031/viewer/2022020107/5750739c1a28abdd2e905017/html5/thumbnails/4.jpg)
1.2. Strengths
1.2.1. Local data
This approach affords sites, whether health-care facilities or school systems, the
opportunity to utilize findings based on their own patients, eliminating concerns about
the extent to which studies in the scholarly literature are applicable to their specific
circumstances. National data from similar treatment settings are also provided to provide
context in which to interpret a site’s data. Additionally, the data are based on functionally-
written FCMs, which non-clinical audiences should find easier to understand than many
clinical measures in widespread use. Finally, NOMS is an approved outcomes measure-
ment system under the Joint Commission on the Accreditation of Healthcare Organiza-
tions’ (JCAHO) ORYX Initiative, allowing participating facilities to use NOMS in meeting
their accreditation requirements.
1.2.2. Statistical power
As of the Fall 2003, the Adult NOMS database contained records of over 100,000 patient
stays, with the Schools database containing approximately 15,000 records, and 8000 in
Pre-Kindergarten. These large data sets provide ample statistical power for most descrip-
tive analyses.
1.2.3. Hypothesis generation
While NOMS data cannot conclusively demonstrate a direct causal link between SLP or
audiologic interventions and patient outcomes, the data are a valuable starting point for the
development of hypotheses for testing using experimental study designs.
2. Conclusion
A critical analysis of the evidence supporting clinical practice in speech-language
pathology, and alignment of practice with this evidence remains at the core of evidence-
based practice. However, the past decade has seen the emergence of interested parties from
outside of the profession who are also demanding evidence. For these other groups, it will
not be enough to demonstrate that SLP interventions are research-based. Rather, they will
need to be convinced that these interventions result in tangible improvements in patients’
lives. Neither NOMS’ case-series approach nor most other clinical research are ideally
suited to addressing these evidence needs. Treatment effectiveness research combining
functional patient outcome measures with scientifically rigorous controls will be needed to
meet these challenges.
Appendix A. Continuing education
1. The National Outcome Measurement System was developed as an answer to:
a. Third-party payers’ desire to see tangible outcomes of SLP services
b. The emergence of evidence-based practice
416 R. Mullen / Journal of Communication Disorders 37 (2004) 413–417
![Page 5: Evidence for whom?: ASHA’s National Outcomes Measurement System](https://reader031.vdocuments.site/reader031/viewer/2022020107/5750739c1a28abdd2e905017/html5/thumbnails/5.jpg)
c. An increased emphasis on accountability within the school systems
d. A need for additional measures that could be used to educate patients and their
families
e. All of the above
2. The third-party payer is:
a. Typically not a SLP
b. May not appreciate the results of clinical research
c. Typically unaware of the correlation between a test score and functional ability
level
d. Looking for a ‘‘return on investment’’
e. All of the above
3. The NOMS is:
a. A clearing house for functional outcomes data
b. Used to meet the need for evidenced-based practice
c. Both a and b
d. Developed by the American Psychological Association
e. Based on available psychometric and clinical data
4. NOMS collects data in the areas of:
a. Adult treatment
b. Adolescent treatment
c. School-age treatment
d. Kindergarten treatment
e. Both a and c
5. Strengths of NOMS include:
a. The ability to establish a causal link between treatment and outcomes
b. May be used to meet accreditation requirements
c. Provides ample statistical power for descriptive analysis
d. Both b and c
e. Functional Communication Measures are scored subjectively
References
Brown, R. (1973). A first language: The early stages. Cambridge, MA: Harvard University Press.
Goodglass, H., Kaplan, E., & Barresi, B. (2000). Boston Diagnostic Aphasia Examination (3rd ed.). New York:
Lippincott, Williams, Wilkins.
R. Mullen / Journal of Communication Disorders 37 (2004) 413–417 417